ArticleFrontiers in immunology2022

Metabolic Reprogramming of Alloreactive T Cells Through TCR/MYC/mTORC1/E2F6 Signaling in aGvHD Patients.

Zengkai Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.